586 related articles for article (PubMed ID: 28455673)
21. Pre-operative management of Pleomorphic and florid lobular carcinoma in situ of the breast: Report of a large multi-institutional series and review of the literature.
Foschini MP; Miglio R; Fiore R; Baldovini C; Castellano I; Callagy G; Bianchi S; Kaya H; Amendoeira I; Querzoli P; Poli F; Scatena C; Cordoba A; Pietribiasi F; Kovács A; Faistova H; Cserni G; Quinn C
Eur J Surg Oncol; 2019 Dec; 45(12):2279-2286. PubMed ID: 31301938
[TBL] [Abstract][Full Text] [Related]
22. The impact of lobular and ductal breast cancer histology on the metastatic behavior and long term survival of breast cancer patients.
Korhonen T; Kuukasjärvi T; Huhtala H; Alarmo EL; Holli K; Kallioniemi A; Pylkkänen L
Breast; 2013 Dec; 22(6):1119-24. PubMed ID: 23863867
[TBL] [Abstract][Full Text] [Related]
23. Lobular breast cancer: same survival and local control compared with ductal cancer, but should both be treated the same way? analysis of an institutional database over a 10-year period.
Fortunato L; Mascaro A; Poccia I; Andrich R; Amini M; Costarelli L; Cortese G; Farina M; Vitelli C
Ann Surg Oncol; 2012 Apr; 19(4):1107-14. PubMed ID: 21913022
[TBL] [Abstract][Full Text] [Related]
24. Survival outcomes of patients with lobular carcinoma in situ who underwent bilateral mastectomy or partial mastectomy.
Xie ZM; Sun J; Hu ZY; Wu YP; Liu P; Tang J; Xiao XS; Wei WD; Wang X; Xie XM; Yang MT
Eur J Cancer; 2017 Sep; 82():6-15. PubMed ID: 28646773
[TBL] [Abstract][Full Text] [Related]
25. Post-Mastectomy Radiation Therapy for Invasive Lobular Carcinoma: A Comparative Utilization and Outcomes Study.
Stecklein SR; Shen X; Mitchell MP
Clin Breast Cancer; 2016 Aug; 16(4):319-26. PubMed ID: 26943990
[TBL] [Abstract][Full Text] [Related]
26. Impact of the 21-gene recurrence score on outcome in patients with invasive lobular carcinoma of the breast.
Kizy S; Huang JL; Marmor S; Tuttle TM; Hui JYC
Breast Cancer Res Treat; 2017 Oct; 165(3):757-763. PubMed ID: 28647915
[TBL] [Abstract][Full Text] [Related]
27. Synchronous lobular carcinoma in situ and invasive lobular cancer: marker or precursor for invasive lobular carcinoma.
Wallace AS; Xiang D; Hockman L; Arya M; Jeffress J; Wang Z; Dale PS
Eur J Surg Oncol; 2014 Oct; 40(10):1245-9. PubMed ID: 24857380
[TBL] [Abstract][Full Text] [Related]
28. Hormone receptor status does not affect prognosis in metaplastic breast cancer: a population-based analysis with comparison to infiltrating ductal and lobular carcinomas.
Paul Wright G; Davis AT; Koehler TJ; Melnik MK; Chung MH
Ann Surg Oncol; 2014 Oct; 21(11):3497-503. PubMed ID: 24838367
[TBL] [Abstract][Full Text] [Related]
29. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation.
Sasson AR; Fowble B; Hanlon AL; Torosian MH; Freedman G; Boraas M; Sigurdson ER; Hoffman JP; Eisenberg BL; Patchefsky A
Cancer; 2001 May; 91(10):1862-9. PubMed ID: 11346867
[TBL] [Abstract][Full Text] [Related]
30. Risk and survival of chronic myeloid leukemia after breast cancer: A population-based study.
Al-Husseini MJ; Mohamed HH; Saad AM; Gad MM; Atia M; Qaddoora U; Abushouk AI; El-Shinawi M
Curr Probl Cancer; 2019 Jun; 43(3):213-221. PubMed ID: 30195804
[TBL] [Abstract][Full Text] [Related]
31. Patients with invasive lobular breast cancer are less likely to undergo breast-conserving surgery: a population based study in the Netherlands.
Truin W; Roumen RM; Siesling S; van der Heiden-van der Loo M; Duijm LE; Tjan-Heijnen VC; Voogd AC
Ann Surg Oncol; 2015 May; 22(5):1471-8. PubMed ID: 25323475
[TBL] [Abstract][Full Text] [Related]
32. Secondary gastric cancer malignancies following a breast cancer diagnosis: A population-based analysis.
Mahar AL; Kagedan DJ; Hallet J; Coburn NG
Breast; 2017 Jun; 33():34-37. PubMed ID: 28279886
[TBL] [Abstract][Full Text] [Related]
33. Evaluating the Rate of Upgrade to Invasive Breast Cancer and/or Ductal Carcinoma In Situ Following a Core Biopsy Diagnosis of Non-classic Lobular Carcinoma In Situ.
Nakhlis F; Harrison BT; Giess CS; Lester SC; Hughes KS; Coopey SB; King TA
Ann Surg Oncol; 2019 Jan; 26(1):55-61. PubMed ID: 30362065
[TBL] [Abstract][Full Text] [Related]
34. Associations of race and ethnicity with risk of developing invasive breast cancer after lobular carcinoma in situ.
Dania V; Liu Y; Ademuyiwa F; Weber JD; Colditz GA
Breast Cancer Res; 2019 Nov; 21(1):120. PubMed ID: 31727116
[TBL] [Abstract][Full Text] [Related]
35. Trends in incidence and management of lobular carcinoma in situ: a population-based analysis.
Portschy PR; Marmor S; Nzara R; Virnig BA; Tuttle TM
Ann Surg Oncol; 2013 Oct; 20(10):3240-6. PubMed ID: 23846782
[TBL] [Abstract][Full Text] [Related]
36. Invasive lobular carcinoma of the breast: A special histological type compared with invasive ductal carcinoma.
Chen Z; Yang J; Li S; Lv M; Shen Y; Wang B; Li P; Yi M; Zhao X; Zhang L; Wang L; Yang J
PLoS One; 2017; 12(9):e0182397. PubMed ID: 28863134
[TBL] [Abstract][Full Text] [Related]
37. Comparison of Treatment Outcome Between Invasive Lobular and Ductal Carcinomas in Patients Receiving Partial Breast Irradiation With Intraoperative Electrons.
Leonardi MC; Maisonneuve P; Mastropasqua MG; Cattani F; Fanetti G; Morra A; Lazzari R; Bazzani F; Caputo M; Rotmensz N; Gerardi MA; Ricotti R; Enrica Galimberti V; Veronesi P; Dicuonzo S; Viale G; Jereczek-Fossa BA; Orecchia R
Int J Radiat Oncol Biol Phys; 2017 Sep; 99(1):173-181. PubMed ID: 28816144
[TBL] [Abstract][Full Text] [Related]
38. Survival Outcomes in Premenopausal Patients With Invasive Lobular Carcinoma.
Yoon TI; Jeong J; Lee S; Ryu JM; Lee YJ; Lee JY; Hwang KT; Kim H; Kim S; Lee SB; Ko BS; Lee JW; Son BH; Metzger O; Kim HJ
JAMA Netw Open; 2023 Nov; 6(11):e2342270. PubMed ID: 37938845
[TBL] [Abstract][Full Text] [Related]
39. The risk of a contralateral breast cancer among women diagnosed with ductal and lobular breast carcinoma in situ: data from the Connecticut Tumor Registry.
Claus EB; Stowe M; Carter D; Holford T
Breast; 2003 Dec; 12(6):451-6. PubMed ID: 14659121
[TBL] [Abstract][Full Text] [Related]
40. Carcinoma In Situ Involving Sclerosing Adenosis: Seeking the Salient Histological Characteristics to Prevent Overdiagnosis.
Cui X; Wei S
Ann Clin Lab Sci; 2017 Sep; 47(5):529-534. PubMed ID: 29066477
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]